Aptilon Announces Expanded Contracts

    MONTREAL, Sept. 4 /CNW/ - Aptilon Corporation ("Aptilon" or the
"Corporation") (TSX-V: APZ), an innovative leader of online marketing services
to physicians, today announced the extension and expansion of contracts with
its largest client for the sixth consecutive year and another top 10 U.S.
pharmaceutical manufacturer for the second year. Under terms of the
agreements, which commence in 2008 and extend for 12 months, Aptilon is
connecting high profile physicians with an increased number of pharmaceutical
brands. Up to $5 million of work will be delivered under these
performance-based contracts with the possibility that additional services will
be added.
    Chairman and CEO Dr. Roger Korman stated, "By extending our market lead
in providing live video connectivity to physicians, Aptilon further entrenches
its position in top US pharmaceutical companies. The expansion of these client
commitments strengthens Aptilon's ability to grow organically through
sustainable repeat. Clients are renewing their commitments to Aptilon on the
basis of the measurable results they achieve."
    The contracts center on Aptilon providing its AxcelRx(SM) "click to talk"
video connection software so that doctors can connect to pharmaceutical
service representatives through a live video link at their convenience.
Aptilon has demonstrated these sales representative-physician dialogues last
on average more than eight minutes, which is considerably longer than the
typical encounter in the office.
    Dr. Korman added, "Our recent acquisitions have enabled us to reach an
expanded number of high profile US physicians who benefit from the kinds of
programs offered by innovative pharmaceutical companies. Physicians are
looking for an efficient means to get the drug information they require and,
in these days of cost constraint, top US pharmaceutical companies are
searching for the optimal deployment of their promotional resources. Aptilon
AxcelRx(SM) platform meets both their needs."

    About Aptilon Corporation
    Aptilon enables pharmaceutical, biotech and medical device companies to
effectively reach and interact with more than 450,000 US physicians via the
Internet through its innovative AxcelRx(SM) Live video detailing platform
which hosts promotional, peer selling and other sales and marketing programs.
Top ten US pharmaceutical companies have adopted Aptilon's AxcelRx(SM)
solution to reach leading physicians. Aptilon provides the infrastructure
necessary for pharmaceutical companies to build physician awareness,
understanding, and product preference during all stages of a product's life
cycle, from pre-launch education through end stage support. For more
information, visit www.aptilon.com.
    AxcelRx(SM) and ReachNet(SM) are service marks of Aptilon Corporation.

     The TSX Venture Exchange Inc. has not reviewed and does not accept
         responsibility for the adequacy or accuracy of this release.

    %SEDAR: 00022191EF

For further information:

For further information: Denis Martineau, President, Aptilon
Corporation, 1-888-544-8866, investors@aptilon.com; Arianna Vanin, Investor
Relations, The Equicom Group, (514) 844-4680, avanin@equicomgroup.com

Organization Profile

DMD Digital Health Connections Group Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890